Citation Impact
Citing Papers
Origins and evolution of the Western diet: health implications for the 21st century1,2
2005 Standout
Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases
2002
Long-term supplementation with n-3 fatty acids, II: effect on neutrophil and monocyte chemotaxis
1992
Atopic Dermatitis
2008 Standout
Toxoplasmosis
2004 Standout
Toxoplasmic Myocarditis and Polymyositis in Patients with Acute Acquired Toxoplasmosis Diagnosed During Life
1997
IL-31: A new link between T cells and pruritus in atopic skin inflammation
2006 Standout
Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis
2012 Standout
Atopic dermatitis
2003 Standout
The Effect of Dietary Supplementation with n—3 Polyunsaturated Fatty Acids on the Synthesis of Interleukin-1 and Tumor Necrosis Factor by Mononuclear Cells
1989 Standout
Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines
1993 Standout
Pathogenesis and clinical features of psoriasis
2007 Standout
Skin manifestations of sarcoidosis
2012
Itch
2003
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Cyclosporin in the treatment of patients with atopic eczema – a systematic review and meta‐analysis
2007
Atopic dermatitis
2015 Standout
Microemulsion-based media as novel drug delivery systems
2000 Standout
Quality of life bibliography and indexes: 1993 update
1995
Skindex, a Quality-of-Life Measure for Patients with Skin Disease: Reliability, Validity, and Responsiveness
1996
Omega-3 fatty acids in health and disease and in growth and development
1991 Standout
Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials
2005
The Oslo definitions for coeliac disease and related terms
2012 Standout
IgE and mast cells in allergic disease
2012 Standout
Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology
2014
The effect of n-3 fatty acids on neutrophil chemiluminescence
1995
Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
1996
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
2008 Standout
Assessment of Quality-of-Life Outcomes
1996 Standout
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
2014 Standout
Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.
1994
Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis
1998
Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells
2003 Standout
Questionnaire techniques in assessing acne handicap: Reliability and validity study
1996
Sarcoidosis
2013 Standout
Skeletal remodeling in health and disease
2007 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Pathologic Classification of Diabetic Nephropathy
2010 Standout
Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
2012 Standout
Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan
2010
Withdrawal syndrome following cessation of antihypertensive drug therapy
2005
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Tick immunity using mRNA, DNA and protein-based Salp14 delivery strategies
2021 StandoutNobel
Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: A randomized controlled trial
2011
Atopic dermatitis: New insights and opportunities for therapeutic intervention
2000
Comparative responsiveness of generic and specific quality-of-life instruments
2003
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
2006 Standout
Transdermal drug delivery
2008 Standout
DISABILITY AND HANDICAP IN DERMATOLOGY
1996
Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: A systematic review
2013
The World Health Organization's WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A Report from the WHOQOL Group
2004 Standout
Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell–attracting chemokine (CTACK) levels in allergic diseases
2004
Disseminated Strongyloides stercoralis: Hyperinfection during medical immunosuppression
2010
The effect of severe psoriasis on the quality of life of 369 patients
2006
What are the best outcome measurements for atopic eczema? A systematic review
2007
Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation
2000
Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial
2001
Clinical Features and Metabolic and Autoimmune Derangements in Acquired Partial Lipodystrophy
2004
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis
2002
Basal cell carcinomas cause little handicap
1996
Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7)
2005 Standout
Dietary Supplementation with Ethyl Ester Concentrates of Fish Oil (n-3) and Borage Oil (n-6) Polyunsaturated Fatty Acids Induces Epidermal Generation of Local Putative Anti-Inflammatory Metabolites
1991
Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis
2001
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Dermatology in-patient management greatly improves life quality
1995
A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED TRIAL OF FISH OIL IN PSORIASIS
1988
Skin manifestations of celiac disease
2005
Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis
1996
Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts
2002 Standout
Induction of human IgE synthesis in B cells by mast cells and basophils
1993 Nature
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response
2000 Standout
The importance of the ratio of omega-6/omega-3 essential fatty acids
2002 Standout
A review of the epidemiology of psoriasis vulgaris in the community
1998
Mast cells in the development of adaptive immune responses
2005 Standout
Atopic Dermatitis in Italian Children: Evaluation of Its Economic Impact
2006
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
2002 Standout
Human health implications of environmental contaminants in Arctic Canada: a review
1999 Standout
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
1998 StandoutNature
Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt
2012
Quality of life in atopic dermatitis
2001
Effects of probiotics on atopic dermatitis: a randomised controlled trial
2005
Effect of cyclosporin A on the allergen-induced late asthmatic reaction
1997
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Telomerase Activity Is Increased and Telomere Length Shortened in T Cells from Blood of Patients with Atopic Dermatitis and Psoriasis
2000
IS HOMOEOPATHY A PLACEBO RESPONSE? CONTROLLED TRIAL OF HOMOEOPATHIC POTENCY, WITH POLLEN IN HAYFEVER AS MODEL
1986
Measures of the effect of adult severe atopic eczema on quality of life
1996
Gut Microbiota in Health and Disease
2010 Standout
Measurement of disease activity and outcome in atopic dermatitis
1996
Pessimism correlates with leukocyte telomere shortness and elevated interleukin-6 in post-menopausal women
2008 StandoutNobel
House dust mite reduction and avoidance measures for treating eczema
2015
T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia.
1996
Comparison of cyclosporin A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis
1997
Systematic review of treatments for atopic eczema.
2000
HEALTH STATUS ASSESSMENT METHODS FOR ADULTS: Past Accomplishments and Future Challenges
1999
Inflammatory Muscle Diseases
2015 Standout
The significance of polyunsaturated fatty acids in cutaneous biology
1996
Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial
2015
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Immunomodulation of host responses to ectoparasite infestation – an overview
1984
Atopic dermatitis: A practice parameter update 2012
2013
The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation
2005
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation
2004
The PPARs: From Orphan Receptors to Drug Discovery
2000 Standout
Leukotrienes and Other Lipoxygenase Products in the Pathogenesis and Therapy of Psoriasis and Other Dermatoses
1983
Clinical and biochemical effects of coenzyme Q10, vitamin E, and selenium supplementation to psoriasis patients
2008
Quality of life measurement in dermatology: a practical guide
1997 Standout
Quality-of-Life Issues and Economic Burden of Psoriasis and Atopic Dermatitis
1995
The Metabolic Syndrome
2008 Standout
Comparison of cyclosporin A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis
1997
Mycophenolate mofetil is effective in the treatment of atopic dermatitis.
2001
Works of B.R. Allen being referenced
Benoxaprofen: effect on cutaneous lesions in psoriasis.
1982
Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis
1991
Fish Oil in Combination with Other Therapies in the Treatment of Psoriasis
2015
Dermatomyositis responding to treatment of associated toxoplasmosis
1991
The effects of dietary supplementation with fish oil in patients with psoriasis
1987
Dermatomyositis associated with malignant melanoma-case report and review of the literature
1994
Treatment of severe atopic dermatitis in childhood with cyclosporin
1996
Cyclosporine in severe childhood atopic dermatitis: A multicenter study
1996
Low systemic exposure in infants with atopic dermatitis in a 1‐year pharmacokinetic study with pimecrolimus cream 1%*
2006
Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis
1997
(23) Dermatitis herpetiformis
1978
Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis
1997
Bethanidine in hypertension.
1968
(21) Partial lipodystrophy
1978
What is the cost of atopic dermatitis in preschool children?
2001
Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial
1993
Norwegian scabies during immunosuppressive therapy.
1973
Nail dystrophy due to sarcoidosis
1981